These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. PKCε mediates resistin-induced NADPH oxidase activation and inflammation leading to smooth muscle cell dysfunction and intimal hyperplasia. Raghuraman G; Zuniga MC; Yuan H; Zhou W Atherosclerosis; 2016 Oct; 253():29-37. PubMed ID: 27573736 [TBL] [Abstract][Full Text] [Related]
34. Elevated systemic TGF-beta impairs aortic vasomotor function through activation of NADPH oxidase-driven superoxide production and leads to hypertension, myocardial remodeling, and increased plaque formation in apoE(-/-) mice. Buday A; Orsy P; Godó M; Mózes M; Kökény G; Lacza Z; Koller A; Ungvári Z; Gross ML; Benyó Z; Hamar P Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H386-95. PubMed ID: 20511416 [TBL] [Abstract][Full Text] [Related]
35. Liraglutide Attenuates Preestablished Atherosclerosis in Apolipoprotein E-Deficient Mice via Regulation of Immune Cell Phenotypes and Proinflammatory Mediators. Bruen R; Curley S; Kajani S; Lynch G; O'Reilly ME; Dillon ET; Brennan EP; Barry M; Sheehan S; McGillicuddy FC; Belton O J Pharmacol Exp Ther; 2019 Sep; 370(3):447-458. PubMed ID: 31270216 [TBL] [Abstract][Full Text] [Related]
36. NADPH oxidase 1/4 inhibition attenuates the portal hypertensive syndrome via modulation of mesenteric angiogenesis and arterial hyporeactivity in rats. Deng W; Duan M; Qian B; Zhu Y; Lin J; Zheng L; Zhang C; Qi X; Luo M Clin Res Hepatol Gastroenterol; 2019 Jun; 43(3):255-265. PubMed ID: 30413372 [TBL] [Abstract][Full Text] [Related]
37. Glucose-dependent insulinotropic polypeptide prevents the progression of macrophage-driven atherosclerosis in diabetic apolipoprotein E-null mice. Nogi Y; Nagashima M; Terasaki M; Nohtomi K; Watanabe T; Hirano T PLoS One; 2012; 7(4):e35683. PubMed ID: 22536426 [TBL] [Abstract][Full Text] [Related]
38. Aldehyde dehydrogenase 2 deficiency promotes atherosclerotic plaque instability through accelerating mitochondrial ROS-mediated vascular smooth muscle cell senescence. Zhu H; Wang Z; Dong Z; Wang C; Cao Q; Fan F; Zhao J; Liu X; Yuan M; Sun X; Peng X; Zou Y; Zhou J; Ge J; Zhou X; Zhang Y Biochim Biophys Acta Mol Basis Dis; 2019 Jul; 1865(7):1782-1792. PubMed ID: 30315930 [TBL] [Abstract][Full Text] [Related]
39. IL-9 aggravates the development of atherosclerosis in ApoE-/- mice. Zhang W; Tang T; Nie D; Wen S; Jia C; Zhu Z; Xia N; Nie S; Zhou S; Jiao J; Dong W; Lv B; Xu T; Sun B; Lu Y; Li Y; Cheng L; Liao Y; Cheng X Cardiovasc Res; 2015 Jun; 106(3):453-64. PubMed ID: 25784693 [TBL] [Abstract][Full Text] [Related]
40. Reduced plaque formation induced by rosiglitazone in an STZ-diabetes mouse model of atherosclerosis is associated with downregulation of adhesion molecules. Tikellis C; Jandeleit-Dahm KA; Sheehy K; Murphy A; Chin-Dusting J; Kling D; Sebokova E; Cooper ME; Mizrahi J; Woollard KJ Atherosclerosis; 2008 Jul; 199(1):55-64. PubMed ID: 18093596 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]